Cytek Biosciences, Inc. (CTKB) scores 44 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $1.13, representing a 76% premium to fair value. Quantitative score: 59/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.